Aimei Health Technology Co., Ltd
AFJK
$11.15
$0.0150.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 169.14% | 928.13% | 8,486.11% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 169.14% | 928.13% | 8,486.11% | ||
| Operating Income | -169.14% | -928.13% | -8,486.11% | ||
| Income Before Tax | -75.55% | 70.35% | 17,019.44% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -75.55% | 70.35% | 17,019.44% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -75.55% | 70.35% | 17,019.44% | ||
| EBIT | -169.14% | -928.13% | -8,486.11% | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | -69.65% | -2.19% | 2,427.59% | ||
| Normalized Basic EPS | -69.79% | -1.91% | 2,444.44% | ||
| EPS Diluted | -69.65% | -2.19% | 2,427.59% | ||
| Normalized Diluted EPS | -69.79% | -1.91% | 2,444.44% | ||
| Average Basic Shares Outstanding | -19.31% | 74.08% | 622.08% | ||
| Average Diluted Shares Outstanding | -19.31% | 74.08% | 622.08% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||